Evidence map›Paper›PMID 37880305›Full record

ArticleScientific reports2023

Cocaine-induced loss of LTD and social impairments are restored by fatty acid amide hydrolase inhibition.

Laia Alegre-Zurano, Alba Caceres-Rodriguez, Paula Berbegal-Sáez, Olivier Lassalle, Olivier Manzoni, Olga Valverde

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Laia Alegre-ZuranoNeurobiology of Behaviour Research Group (GReNeC-NeuroBio), Department of Medicine and Life Sciences, Universitat Pompeu Fabra, C/ Dr Aiguader, 88, 08003, Barcelona, Spain.
Alba Caceres-RodriguezINMED, INSERM U1249, Marseille, France.
Paula Berbegal-SáezNeurobiology of Behaviour Research Group (GReNeC-NeuroBio), Department of Medicine and Life Sciences, Universitat Pompeu Fabra, C/ Dr Aiguader, 88, 08003, Barcelona, Spain.
Olivier LassalleINMED, INSERM U1249, Marseille, France.
Olivier Manzoni *INMED, INSERM U1249, Marseille, France.
Olga Valverde *Neurobiology of Behaviour Research Group (GReNeC-NeuroBio), Department of Medicine and Life Sciences, Universitat Pompeu Fabra, C/ Dr Aiguader, 88, 08003, Barcelona, Spain. olga.valverde@upf.edu.
Pompeu Fabra University · ESAix-Marseille Université · FRHospital Del Mar · ESInserm · FRInstitut de Neurobiologie de la Méditerranée · FR

Funding

DRUG ABUSE &REGULATORY ENZYMES OF BIOGENIC AMINESR01DA000869 · NIDA · UNIVERSITY OF UTAH · PI FLECKENSTEIN, ANNETTE · 1985 to 2010
$2.9M
6 · The paper itself

Abstract

A single dose of cocaine abolishes endocannabinoid-mediated long-term depression (eCB-LTD) in the nucleus accumbens (NAc) within 24 h of administration. However, it is uncertain whether this altered neuroplasticity entails a behavioral deficit. As previously reported, after a single dose of cocaine (20 mg/kg), mice displayed impaired eCB-LTD in the NAc. Such cocaine-induced neuroplastic impairment was accompanied by an altered preference for saccharin and social interactions and a reduction in mRNA levels of the anandamide-catabolizing enzyme NAPE-PLD. The pharmacological increase of anandamide through the fatty acid amide hydrolase (FAAH) inhibitor URB597 (1 mg/kg) reversed the cocaine-induced loss of eCB-LTD in the NAc and restored normal social interaction in cocaine-exposed mice, but it did not affect saccharin preference. Overall, this research underlines the neuroplastic and behavioral alterations occurring after the initial use of cocaine and suggests a potential role for anandamide.

Indexed as

CocaineLong-Term Synaptic DepressionAmidohydrolasesAnimalsArachidonic AcidsEndocannabinoidsFatty Acid Amide HydrolasesMicePolyunsaturated AlkamidesSaccharinAmidohydrolasesanandamideArachidonic AcidsCocaineEndocannabinoidsFatty Acid Amide HydrolasesPolyunsaturated AlkamidesSaccharin

Identifiers

PMID37880305
PMCPMC10600200
OpenAlexW4387940258

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.